Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IPO9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBAP2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SGCB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR3658 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHTOP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF32 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FLAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNGR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF281 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALDH9A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS18C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASSF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM20B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PMF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBQLN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on